CENTRE OSCAR LAMBRET
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1995-01-01
- Employees
- 251
- Market Cap
- -
Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic Meningitis (Exo-LCR)
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Procedure: ConsultationProcedure: Cerebral and medullary MRI, lumbar puncture, CSF samplingBiological: biological test
- First Posted Date
- 2022-03-18
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 7
- Registration Number
- NCT05286684
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, Hauts de France, France
Prospective Cohort With Clinic-biologic Database of Patients Treated by Immunotherapy
Not Applicable
Recruiting
- Conditions
- Solid Tumor, Adult
- Interventions
- Other: ImmuCCo Cohort
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 500
- Registration Number
- NCT05223608
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, Hauts-de-France, France
Cohort Study to Determine the Antitumor Activity of New CAR-macrophages in Breast Cancer Patients' Derived Organoids
- Conditions
- Breast Cancer
- First Posted Date
- 2021-08-16
- Last Posted Date
- 2021-08-16
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 100
- Registration Number
- NCT05007379
Impact of Peritoneal Gas Drain on Postoperative Pain for Gynaecological Cancer Patients With Minimally Invasive Surgery
Not Applicable
Completed
- Conditions
- Gynaecologic Cancer
- Interventions
- Procedure: DrainProcedure: Manual exsufflation
- First Posted Date
- 2021-07-23
- Last Posted Date
- 2023-12-15
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 202
- Registration Number
- NCT04974125
- Locations
- 🇫🇷
Fabrice NARDUCCI, Lille, France
Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer
Not Applicable
Active, not recruiting
- Conditions
- Advanced Breast Cancer
- First Posted Date
- 2020-12-04
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 25
- Registration Number
- NCT04653740
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
Impact of Personalized and Remote Support Centered on Exercise and Physical Activity for Breast Cancer Patients
Not Applicable
Completed
- Conditions
- Breast Cancer Female
- Interventions
- Other: Standard supportive approach (Arm B)Other: Personalized Coaching (Arm A)
- First Posted Date
- 2020-09-02
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 824
- Registration Number
- NCT04536584
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, Auvergne-Rhône-Alpes, France
🇫🇷Groupe Hospitalier Bretagne Sud, Lorient, Bretagne, France
🇫🇷CARIO Hôpital Privé des Côtes d'Armor, Plérin, Bretagne, France
Evaluation of the Photobiomodulation Using LED Lamp for Curative Treatment of Radio-induced Mucositis.
Phase 2
Completed
- Conditions
- Oral CancerOropharyngeal Cancer
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2022-12-06
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 28
- Registration Number
- NCT04251949
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
Mechanical Stimulation on Pain Level and Functional Discomfort After Breast Cancer Surgery
Not Applicable
Terminated
- Conditions
- Breast Cancer
- Interventions
- Procedure: MassagesProcedure: Mechanical Stimulation
- First Posted Date
- 2019-12-17
- Last Posted Date
- 2024-01-02
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 80
- Registration Number
- NCT04202640
- Locations
- 🇫🇷
Centre Hospitalier Universitaire de Lille, Lille, France
🇫🇷Centre Oscar Lambret, Lille, Hauts-de- France, France
Carboplatin-Paclitaxel Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer
Phase 2
Terminated
- Conditions
- Cervical CancerLocally Advanced Cancer
- Interventions
- Drug: Carboplatin-Paclitaxel adjuvant chemotherapy
- First Posted Date
- 2019-07-11
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 21
- Registration Number
- NCT04016142
- Locations
- 🇫🇷
Centre Marie Curie, Arras, France
🇫🇷Centre Pierre Curie, Beuvry, France
🇫🇷Centre Léonard de Vinci, Dechy, France
Feasibility of a New Technology for Isolating Circulating Tumour Cells
Not Applicable
- Conditions
- Circulating Tumor CellHER2-positive Metastatic Breast CancerHormone-resistant Prostate CancerOvarian Cancer
- Interventions
- Procedure: Blood sample collection
- First Posted Date
- 2019-06-07
- Last Posted Date
- 2021-10-13
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 76
- Registration Number
- NCT03979339
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
© Copyright 2025. All Rights Reserved by MedPath